Rocca Y - Search Results

1

Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.

Besson L, Mery B, Morelle M, Rocca Y, Heudel PE, You B, Bachelot T, Ray-Coquard I, Villard M, Charrier E, Parant F, Viel S, Garin G, Mayet R, Perol D, Walzer T, Tredan O, Marçais A. Besson L, et al. Among authors: rocca y. J Immunol. 2021 May 15;206(10):2265-2270. doi: 10.4049/jimmunol.2001215. Epub 2021 Apr 30. J Immunol. 2021. PMID: 33931486 Clinical Trial.

2

Combinatorial Expression of NK Cell Receptors Governs Cell Subset Reactivity and Effector Functions but Not Tumor Specificity.

Rocca Y, Pouxvielh K, Marotel M, Benezech S, Jaeger B, Allatif O, Bendriss-Vermare N, Marçais A, Walzer T. Rocca Y, et al. J Immunol. 2022 Apr 1;208(7):1802-1812. doi: 10.4049/jimmunol.2100874. Epub 2022 Mar 14. J Immunol. 2022. PMID: 35288470

3

Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion.

Marotel M, Villard M, Drouillard A, Tout I, Besson L, Allatif O, Pujol M, Rocca Y, Ainouze M, Roblot G, Viel S, Gomez M, Loustaud V, Alain S, Durantel D, Walzer T, Hasan U, Marçais A. Marotel M, et al. Among authors: rocca y. Elife. 2021 Jan 28;10:e60095. doi: 10.7554/eLife.60095. Elife. 2021. PMID: 33507150 Free PMC article.

4

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.

Rocca YS, Roberti MP, Juliá EP, Pampena MB, Bruno L, Rivero S, Huertas E, Sánchez Loria F, Pairola A, Caignard A, Mordoh J, Levy EM. Rocca YS, et al. Front Immunol. 2016 Oct 10;7:413. doi: 10.3389/fimmu.2016.00413. eCollection 2016. Front Immunol. 2016. PMID: 27777574 Free PMC article.

5

Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.

Roberti MP, Juliá EP, Rocca YS, Amat M, Bravo AI, Loza J, Coló F, Loza CM, Fabiano V, Maino M, Podhorzer A, Fainboim L, Barrio MM, Mordoh J, Levy EM. Roberti MP, et al. Eur J Immunol. 2015 May;45(5):1560-9. doi: 10.1002/eji.201445353. Epub 2015 Apr 7. Eur J Immunol. 2015. PMID: 25726929 Free article.

6

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients.

Roberti MP, Rocca YS, Amat M, Pampena MB, Loza J, Coló F, Fabiano V, Loza CM, Arriaga JM, Bianchini M, Barrio MM, Bravo AI, Domenichini E, Chacón R, Mordoh J, Levy EM. Roberti MP, et al. Breast Cancer Res Treat. 2012 Dec;136(3):659-71. doi: 10.1007/s10549-012-2287-y. Epub 2012 Oct 14. Breast Cancer Res Treat. 2012. PMID: 23065032

7

Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients.

Rocca YS, Roberti MP, Arriaga JM, Amat M, Bruno L, Pampena MB, Huertas E, Loria FS, Pairola A, Bianchini M, Mordoh J, Levy EM. Rocca YS, et al. Innate Immun. 2013 Feb;19(1):76-85. doi: 10.1177/1753425912453187. Epub 2012 Jul 10. Innate Immun. 2013. PMID: 22781631 Free article.

8

IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.

Roberti MP, Barrio MM, Bravo AI, Rocca YS, Arriaga JM, Bianchini M, Mordoh J, Levy EM. Roberti MP, et al. Among authors: rocca ys. Breast Cancer Res Treat. 2011 Nov;130(2):465-75. doi: 10.1007/s10549-011-1360-2. Epub 2011 Feb 10. Breast Cancer Res Treat. 2011. PMID: 21308409

9

Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.

Arriaga JM, Bravo IA, Bruno L, Morales Bayo S, Hannois A, Sanchez Loria F, Pairola F, Huertas E, Roberti MP, Rocca YS, Aris M, Barrio MM, Baffa Trasci S, Levy EM, Mordoh J, Bianchini M. Arriaga JM, et al. Among authors: rocca ys. Hum Pathol. 2012 Oct;43(10):1695-703. doi: 10.1016/j.humpath.2011.12.014. Epub 2012 Apr 17. Hum Pathol. 2012. PMID: 22516242

10

Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.

Vogt M, Dudvarski Stankovic N, Cruz Garcia Y, Hofstetter J, Schneider K, Kuybu F, Hauck T, Adhikari B, Hamann A, Rocca Y, Grysczyk L, Martin B, Gebhardt-Wolf A, Wiegering A, Diefenbacher M, Gasteiger G, Knapp S, Saur D, Eilers M, Rosenfeldt M, Erhard F, Vos SM, Wolf E. Vogt M, et al. Among authors: rocca y. Gut. 2024 May 31:gutjnl-2023-331519. doi: 10.1136/gutjnl-2023-331519. Online ahead of print. Gut. 2024. PMID: 38821858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page